Arena Pharma (ARNA) Tops Q1 EPS by 8068c

May 8, 2018 4:03 PM EDT

Arena Pharma (NASDAQ: ARNA) reported Q1 EPS of $80.00, $80.68 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $2.76 million.

For earnings history and earnings-related data on Arena Pharma (ARNA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings